Literature DB >> 1371150

Comparison of the N-linked oligosaccharide structures of the two major human myelin glycoproteins MAG and P0: assessment of the structures bearing the epitope for HNK-1 and human monoclonal immunoglobulin M found in demyelinating neuropathy.

D Burger1, G Perruisseau, M Simon, A J Steck.   

Abstract

The epitope for HNK-1 and patient's monoclonal autoantibodies in demyelinating polyneuropathy associated with immunoglobulin M gammopathy is borne by different types of N-linked oligosaccharide structures in human P0 and myelin-associated glycoprotein (MAG). Fourteen glycopeptide fractions bearing different oligosaccharide structures were obtained from either MAG or P0 glycopeptides by serial lectin affinity chromatography on concanavalin A-Sepharose, Phaseolus vulgaris erythrophytohemagglutinin-agarose, Pisum sativum agglutinin-agarose, and Phaseolus vulgaris leucophytohemagglutinin-agarose. As shown by dot-TLC plate immunostaining, the same MAG and P0 glycopeptide fractions were recognized by HNK-1 and patient's immunoglobulin M, confirming that these antibodies display similar specificities. The antigenic carbohydrate was present in glycopeptide fractions that either interact with Pisum sativum agglutinin-agarose or were bound by Aleuria aurantia agglutinin-digoxigenin, indicating that these structures contained alpha(1-6)fucose residues. This study demonstrates that the L2/HNK-1 epitope is borne mainly or even exclusively by N-linked oligosaccharide structures alpha(1-6)fucosylated in the core.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371150     DOI: 10.1111/j.1471-4159.1992.tb09335.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire.

Authors:  Jens O Watzlawik; Bharath Wootla; Meghan M Painter; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2013-09       Impact factor: 4.618

2.  Antibodies to myelin P0 and ceramide perpetuate neuropathy in long standing treated leprosy patients.

Authors:  Renuka Raju; S Karuna Devi; C Mehervani; A Shiva Kumar; A K Meena; P P Reddy; Penaguluru Pranay; Suman Jain; J J Archelos-Gracia; Sujai Suneetha; Lavanya M Suneetha
Journal:  Neurochem Res       Date:  2011-01-14       Impact factor: 3.996

Review 3.  Glycoproteins of myelin sheaths.

Authors:  R H Quarles
Journal:  J Mol Neurosci       Date:  1997-02       Impact factor: 3.444

4.  The N-glycan acceptor specificity of a glucuronyltransferase, GlcAT-P, associated with biosynthesis of the HNK-1 epitope.

Authors:  S Oka; K Terayama; K Imiya; S Yamamoto; A Kondo; I Kato; T Kawasaki
Journal:  Glycoconj J       Date:  2000-12       Impact factor: 2.916

5.  Post-translational modifications of apolipoprotein A-I and Po proteins in the avian peripheral nerve.

Authors:  J Lemieux; S Giannoulis; W C Breckenridge; C Mezei
Journal:  Neurochem Res       Date:  1995-03       Impact factor: 3.996

6.  Tomaculous neuropathy in chromosome 1 Charcot-Marie-Tooth syndrome.

Authors:  F P Thomas; R V Lebo; G Rosoklija; X S Ding; R E Lovelace; N Latov; A P Hays
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 7.  Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2018-01-15       Impact factor: 6.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.